Saluda Medical Announces $150M Equity Financing

Artarmon, NSW & Bloomington, MN – April 13, 2023 – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the closing of a US $150…Read More

Read More
LogicMark, Inc. Announces Closing of $5.2 Million Underwritten Public Offering Priced Above Market

LOUISVILLE, KY, Jan. 25, 2023 (GLOBE NEWSWIRE) – LogicMark, Inc. (Nasdaq: LGMK) (the “Company” or “LogicMark”), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced the closing of its above market underwritten public offering.  Gross proceeds, before deducting underwriting…Read More

Read More
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences

PITTSBURGH – Jan. 3, 2023 – Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris’…Read More

Read More
Soleno Therapeutics Announces Financing Commitment for up to $60 Million

REDWOOD CITY, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced it has entered into a Securities Purchase Agreement with Nantahala Capital Management, LLC, Abingworth LLP and Vivo Capital, LLC for…Read More

Read More
Curevo Vaccine Announces $26M Series A-1 Financing

SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More

Read More